0001077183-21-000082.txt : 20210303
0001077183-21-000082.hdr.sgml : 20210303
20210303201741
ACCESSION NUMBER: 0001077183-21-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHOVLIN ROBERT J.
CENTRAL INDEX KEY: 0001621453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 21711943
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_161482063651429.xml
FORM 4
X0306
4
2021-03-01
0
0001077183
NEOGENOMICS INC
NEO
0001621453
SHOVLIN ROBERT J.
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
33913
0
1
0
0
President, Clinical Services
Common Stock
2021-03-01
4
F
0
742
0
D
147528
D
Common Stock
2021-03-02
4
F
0
608
0
D
146920
D
Common Stock
2021-03-02
4
A
0
6827
0
A
153747
D
Stock Option (Right to Buy)
8.03
2023-02-26
Common Stock
96167.0
96167
D
Stock Option (Right to Buy)
19.6
2024-03-01
Common Stock
50173.0
50173
D
Stock Option (Right to Buy)
28.33
2027-03-02
Common Stock
56271.0
56271
D
Stock Option (Right to Buy)
53.17
2021-03-02
4
A
0
38688
53.17
A
2028-03-02
Common Stock
38688.0
38688
D
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date
/s/ Robert J. Shovlin
2021-03-03